AI-Driven Third-Party Systems Pose Growing Operational and Data Risks for Select Medical

Select Medical (SEM) has disclosed a new risk, in the Technology category.

Select Medical faces emerging risks as artificial intelligence and machine learning are increasingly embedded in third‑party systems it relies on but does not control. These technologies may mishandle or inadvertently expose confidential data, embed inaccurate or biased information into critical processes, and evolve in unpredictable ways that could adversely affect the company’s operations and risk profile.

Overall, Wall Street has a Moderate Buy consensus rating on SEM stock based on 1 Buy.

To learn more about Select Medical’s risk factors, click here.